KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 85 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $216,300 | +14.2% | 22,461 | +6.7% | 0.00% | – |
Q2 2023 | $189,423 | +5.5% | 21,047 | -7.8% | 0.00% | – |
Q1 2023 | $179,475 | +48.8% | 22,834 | +27.9% | 0.00% | – |
Q4 2022 | $120,652 | +43.6% | 17,848 | +209.5% | 0.00% | – |
Q3 2022 | $84,000 | +9.1% | 5,766 | -26.4% | 0.00% | – |
Q2 2022 | $77,000 | -92.5% | 7,837 | -88.8% | 0.00% | – |
Q1 2022 | $1,033,000 | +15.9% | 70,068 | +4.0% | 0.00% | – |
Q4 2021 | $891,000 | +284.1% | 67,351 | +408.4% | 0.00% | – |
Q3 2021 | $232,000 | -16.8% | 13,248 | +13.4% | 0.00% | – |
Q2 2021 | $279,000 | -43.4% | 11,687 | -39.1% | 0.00% | – |
Q1 2021 | $493,000 | +97.2% | 19,196 | +45.6% | 0.00% | – |
Q4 2020 | $250,000 | +32.3% | 13,187 | -11.9% | 0.00% | – |
Q3 2020 | $189,000 | -18.2% | 14,965 | -21.4% | 0.00% | – |
Q2 2020 | $231,000 | +51.0% | 19,037 | -4.9% | 0.00% | – |
Q1 2020 | $153,000 | +96.2% | 20,023 | +359.2% | 0.00% | – |
Q4 2019 | $78,000 | -13.3% | 4,360 | -43.2% | 0.00% | – |
Q3 2019 | $90,000 | -20.4% | 7,675 | +50.3% | 0.00% | – |
Q2 2019 | $113,000 | -31.1% | 5,106 | -10.9% | 0.00% | – |
Q1 2019 | $164,000 | +88.5% | 5,729 | +30.4% | 0.00% | – |
Q4 2018 | $87,000 | +1640.0% | 4,394 | +1693.5% | 0.00% | – |
Q3 2018 | $5,000 | – | 245 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |